𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The treatment of tardive dyskinesia with baclofen

✍ Scribed by W. M. Glazer; D. C. Moore; M. B. Bowers; B. S. Bunney; M. Roffman


Publisher
Springer
Year
1985
Tongue
English
Weight
437 KB
Volume
87
Category
Article
ISSN
0033-3158

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Severe tardive dystonia: Treatment with
✍ Dr. Dirk Dressler; Remt-Otto OeljeschlΓ€ger; Eckart RΓΌther πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 302 KB

## Abstract Treatment of tardive dystonia with oral baclofen produces ambivalent and overall disappointing results. However, because only a small proportion of the baclofen penetrates into the central nervous system when administered orally, we tested whether it is possible to increase the efficacy

A pilot study of verapamil in the treatm
✍ Timothy G. Dinan; Claire Capstick πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 237 KB πŸ‘ 1 views

Six patients with severe and stable tardive dyskinesia were treated with verapamil, a calcium channel blocker, in doses ranging from 240 to 400 mg/day. Weekly assessments were made using the Simpson tardive dyskinesia rating scale. Neuroleptic medication was held constant during the 3-month baseline

The life expectancy of schizophrenic pat
✍ Toshiya Inada; Mika Koshiishi; Kimio Ohnishi; Gohei Yagi πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 544 KB

Relationships between tardive dyskinesia (TD) and the life expectancy of schizophrenic patients who suffer it were examined in two studies over a 50-month period. In a prospective study, the mortality rate was found to be higher in patients with T D than in those without. This suggests either that T